Bristol-myers Squibb Compnay

Princeton University

Melda Sezen Edmonds

Benjamin Cohen

Bin Zheng

Yueh-Lin Loo

Jason J Zhu

Michael Anthony Schmidt

Amanda J Rogers

Adam Joseph Freitag

Changxia Yuan

Daniel S Treitler

Chao Hang

Miao Yu

Nicholas C Davy

Geoffrey Eugene Purdum

Siwei Guo

The invention generally relates to an improved processes for the preparation of a cyclic dinucleotide which is useful as a STING agonist of the following formula (I), involving the use of compounds A and B.

Process for the preparation of a cyclic dinucleotide

In one aspect, single-junction organic photovoltaic devices are provided exhibiting high Vvalues while employing single-junction architecture. A single-junction photovoltaic device described herein comprises an anode, a cathode and an active layer residing between the anode and cathode, the active layer comprising an organic electron donor and an organic electron acceptor, wherein the photovoltaic device generates a Vof at least 1.4 V. Uniquely, high Vphotovoltaic devices described herein can be transparent to the majority of visible and/or infrared spectral irradiation in some embodiments.

Sing-junction organic photovoltaic devices having high open-circuit voltages and applications thereof

Growing community of inventors

Princeton, NJ, United States of America

Melda Sezen Edmonds